Studies on the different mechanisms by which heparin and polysulphated xylan (PZ 68) inhibit blood coagulation in man
- 1 August 1981
- journal article
- research article
- Published by Elsevier in Thrombosis Research
- Vol. 23 (4-5), 435-445
- https://doi.org/10.1016/0049-3848(81)90204-8
Abstract
No abstract availableThis publication has 13 references indexed in Scilit:
- Influence on the clotting mechanism of sodium pentosan polysulfate (SP54) in comparison to commercial beef lung sodium heparinThrombosis Research, 1980
- Anticoagulant activities of a pentosane polysulphate: Comparison with standard heparin and a fraction of low molecular weight heparinThrombosis Research, 1980
- Incidences of fatal postoperative pulmonary embolism after prophylaxis with dextran 70 and low-dose heparin: an international multicentre study.BMJ, 1980
- Normal human plasma contains a naturally occurring antagonist of activated factor X inhibitor (antithrombin III) activityThrombosis Research, 1979
- Heparin: An Old Drug with a New ParadigmScience, 1979
- Failure of low-dose heparin to prevent significant thromboembolic complications in high-risk surgical patients: interim report of prospective trial. Groote Schuur Hospital Thromboembolus Study Group.BMJ, 1979
- Comparison of Heparin and a Semi-synthetic Heparin Analogue, A73025.British Journal of Haematology, 1977
- Heparin-accelerated inhibition of activated factor X by its natural plasma inhibitorBiochimica et Biophysica Acta (BBA) - General Subjects, 1970
- Highly Purified Antithrombin III with Heparin Cofactor Activity Prepared by Disc ElectrophoresisScandinavian Journal of Clinical and Laboratory Investigation, 1968
- THE INHIBITION OF BLOOD CLOTTING: AN UNIDENTIFIED SUBSTANCE WHICH ACTS IN CONJUNCTION WITH HEPARIN TO PREVENT THE CONVERSION OF PROTHROMBIN INTO THROMBINAmerican Journal of Physiology-Legacy Content, 1939